Blank-check company Biotech Acquisition Co. and biopharmaceutical group Blade Therapeutics Inc. said Monday they are canceling their previously announced nearly $353 million merger, marking the latest in a number of special-purpose acquisition company transactions that have been terminated recently.
Biotech Acquisition (NASDAQ:BIOT – Get Rating) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 9,800 shares, an increase of 40.0% from the March 15th total of 7,000 shares. Based on an average daily volume of 39,200 shares, the short-interest ratio is presently […]
European Biotech Acquisition Corp. (NASDAQ:EBACU – Get Rating) shares traded up 0.2% during trading on Monday . The company traded as high as $9.84 and last traded at $9.84. 3,265 shares were traded during trading, an increase of 21% from the average session volume of 2,706 shares. The stock had previously closed at $9.82. The […]
Phoenix Biotech Acquisition Corp (NASDAQ:PBAX – Get Rating) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 6,200 shares, a drop of 40.4% from the February 13th total of 10,400 shares. Approximately 0.0% of the company’s stock are sold short. Based on an […]